Stimulation of lung carcinoma cell growth by fibronectin-integrin signalling.
about
The transcription factor ETS-1 regulates angiotensin II-stimulated fibronectin production in mesangial cellsThe Extracellular Matrix in Epithelial Ovarian Cancer - A Piece of a Puzzle.Development of a highly metastatic model that reveals a crucial role of fibronectin in lung cancer cell migration and invasionalpha5beta1-integrin expression is essential for tumor progression in experimental lung cancer.Decreased expression of the long non-coding RNA FENDRR is associated with poor prognosis in gastric cancer and FENDRR regulates gastric cancer cell metastasis by affecting fibronectin1 expression.N-glycoprotein SRMAtlas: a resource of mass spectrometric assays for N-glycosites enabling consistent and multiplexed protein quantification for clinical applications.Gene Signatures Stratify Computed Tomography Screening Detected Lung Cancer in High-Risk Populations.Cytomegalovirus-induced salivary gland pathology: resistance to kinase inhibitors of the upregulated host cell EGFR/ERK pathway is associated with CMV-dependent stromal overexpression of IL-6 and fibronectinEDA-containing fibronectin increases proliferation of embryonic stem cells.The biomechanical integrin.Integrin α5β1, the Fibronectin Receptor, as a Pertinent Therapeutic Target in Solid Tumors.Advanced Glycation End-Products Enhance Lung Cancer Cell Invasion and Migration.Silibinin inhibits triple negative breast cancer cell motility by suppressing TGF-β2 expression.Cellular fibronectin 1 promotes VEGF-C expression, lymphangiogenesis and lymph node metastasis associated with human oral squamous cell carcinoma.Protocatechuic acid inhibits lung cancer cells by modulating FAK, MAPK, and NF-κB pathways.A portable microfluidic device for the rapid diagnosis of cancer metastatic potential which is programmable for temperature and CO2.Fibronectin promotes migration and invasion of ovarian cancer cells through up-regulation of FAK-PI3K/Akt pathway.The EDA-containing cellular fibronectin induces epithelial-mesenchymal transition in lung cancer cells through integrin α9β1-mediated activation of PI3-K/AKT and Erk1/2.Riboflavin at high doses enhances lung cancer cell proliferation, invasion, and migration.Potentiation of tumor cell invasion by co-culture with monocytes accompanying enhanced production of matrix metalloproteinase and fibronectin.Establishment of a highly migratory subclone reveals that CD133 contributes to migration and invasion through epithelial-mesenchymal transition in pancreatic cancer.miRNA-1 targets fibronectin1 and suppresses the migration and invasion of the HEp2 laryngeal squamous carcinoma cell line.Leptin increases motility and integrin up-regulation in human prostate cancer cells.In Vivo Cancer Cells Elimination Guided by Aptamer-Functionalized Gold-Coated Magnetic Nanoparticles and Controlled with Low Frequency Alternating Magnetic Field.Repetitive nicotine exposure leads to a more malignant and metastasis-prone phenotype of SCLC: a molecular insight into the importance of quitting smoking during treatment.Expression and prognostic significance of fibronectin and matrix metalloproteases in breast cancer metastasis.
P2860
Q28573182-8D44CE76-939B-4B61-92C8-C8C92A734AE6Q33361929-1BF8BE91-1122-470B-85D6-05517528EFA2Q33628171-D491CBB2-D37A-4AB0-BF86-8B6878636F8EQ34357105-3B04EEC8-BA31-428F-8F30-415F8B4650AFQ34544488-E9E9A53F-E346-4D78-AE9D-983865919B85Q34585592-7D339854-1E2C-48FA-838A-C31697D0B693Q36038692-4941CA22-E05B-4561-9BB9-B77B722FE178Q36698067-1258AF34-9DF0-4471-8992-0E60C2286B0DQ37308936-5CC65C76-9B15-46AC-AB5E-B30936AF0481Q37610559-FEC205A4-82C7-4C4C-A058-D411BFA13ABAQ38161726-26E834A4-4E0B-4FFA-8FF9-9310A2CAA0B9Q38752287-5ECB83BD-C7DA-4AC3-A5D9-28A09E6B7450Q38785742-207963B3-698D-4A01-80A7-DB57BE2F0969Q38839716-E8D334D0-8D6C-4E1C-95D9-B2CD95988C35Q38943879-0FAF0622-D782-4276-B415-C30487FA3962Q38970306-F76DF1A3-8E77-4123-831D-0C527AC6EEF6Q39081809-1B43F402-9F07-4D47-93C2-BD4EC4246E26Q39113174-851B43F1-3025-47EA-A813-05FFE7AFCFB1Q39212231-DAE5037E-D630-4D5F-8866-52FA917126DFQ39262310-BD1448BE-8D21-4931-A1F2-C32D7FD3E18BQ39438592-94DB1EF0-23ED-4455-8F39-EA058AB612E1Q39472687-37A6967F-B73A-445B-87BA-C629C01A40CCQ39644368-3D1D7ABB-0392-4714-8AFE-6675E412BEEAQ41239491-C51A7BD8-692E-47F1-A692-57F69B2AEC86Q43067202-6A3D2AB6-57F7-4905-97BB-E9BE2B06ECA4Q54777883-485ADE00-1AC7-421D-BB92-0E1D9A8CF1FF
P2860
Stimulation of lung carcinoma cell growth by fibronectin-integrin signalling.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Stimulation of lung carcinoma cell growth by fibronectin-integrin signalling.
@en
Stimulation of lung carcinoma cell growth by fibronectin-integrin signalling.
@nl
type
label
Stimulation of lung carcinoma cell growth by fibronectin-integrin signalling.
@en
Stimulation of lung carcinoma cell growth by fibronectin-integrin signalling.
@nl
prefLabel
Stimulation of lung carcinoma cell growth by fibronectin-integrin signalling.
@en
Stimulation of lung carcinoma cell growth by fibronectin-integrin signalling.
@nl
P2093
P2860
P356
P1433
P1476
Stimulation of lung carcinoma cell growth by fibronectin-integrin signalling.
@en
P2093
Jeffrey D Ritzenthaler
Jesse Roman
Shouwei Han
P2860
P304
P356
10.1039/B800533H
P577
2008-09-09T00:00:00Z